VANGUARD GROUP INC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 84 filers reported holding LEAP THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,091,673
-24.4%
3,210,8020.0%0.00%
Q4 2022$1,444,861
-49.7%
3,210,802
-1.6%
0.00%
Q3 2022$2,872,000
-23.3%
3,264,171
+0.2%
0.00%
Q2 2022$3,744,000
-34.3%
3,256,3310.0%0.00%
Q1 2022$5,699,000
-43.6%
3,256,331
+4.4%
0.00%
Q4 2021$10,106,000
-6.7%
3,119,172
+15.4%
0.00%
Q3 2021$10,837,000
+214.3%
2,702,625
+28.5%
0.00%
Q2 2021$3,448,000
-13.7%
2,102,497
-0.0%
0.00%
Q1 2021$3,996,000
-6.5%
2,102,910
+10.7%
0.00%
Q4 2020$4,273,000
+41.3%
1,899,180
+24.3%
0.00%
Q3 2020$3,025,000
-2.1%
1,528,055
+3.4%
0.00%
Q2 2020$3,089,000
+190.6%
1,477,955
+119.8%
0.00%
Q1 2020$1,063,000
+41.2%
672,5150.0%0.00%
Q4 2019$753,000
-4.3%
672,5150.0%0.00%
Q3 2019$787,000
-20.8%
672,515
+21.1%
0.00%
Q2 2019$994,000
+171.6%
555,195
+183.4%
0.00%
Q1 2019$366,000
+32.6%
195,875
+41.7%
0.00%
Q4 2018$276,000
-86.2%
138,207
-46.1%
0.00%
Q3 2018$1,997,000
+6.7%
256,268
+23.2%
0.00%
Q2 2018$1,872,000
+152.6%
207,968
+132.9%
0.00%
Q1 2018$741,000
+210.0%
89,291
+133.1%
0.00%
Q4 2017$239,000
+12.2%
38,306
+4.4%
0.00%
Q3 2017$213,00036,7060.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 1,810,672$7,261,0002.88%
TANG CAPITAL MANAGEMENT LLC 2,500,000$10,025,0002.08%
Ghost Tree Capital, LLC 1,650,000$6,617,0001.94%
Ally Bridge Group (NY) LLC 1,200,000$4,812,0001.42%
SILVERARC CAPITAL MANAGEMENT, LLC 620,000$2,486,0001.40%
Sio Capital Management, LLC 440,000$1,764,0000.56%
EAM Global Investors LLC 575,610$2,308,0000.55%
EAM Investors, LLC 776,329$3,113,0000.52%
Perceptive Advisors 8,476,496$33,990,0000.49%
Stonepine Capital Management, LLC 250,000$1,003,0000.46%
View complete list of LEAP THERAPEUTICS INC shareholders